• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.32% Nasdaq Down0.62%

    Amyris, Inc. (AMRS)

    -NasdaqGS
    1.02 Up 0.01(0.99%) 4:00PM EDT
    ProfileGet Profile for:
    Amyris, Inc.
    5885 Hollis Street
    Suite 100
    Emeryville, CA 94608
    United States - Map
    Phone: 510-450-0761
    Fax: 510-225-2645
    Website: http://www.amyris.com

    Details 
    Index Membership:N/A
    Sector:Basic Materials
    Industry:Specialty Chemicals
    Full Time Employees:405

    Business Summary 

    Amyris, Inc. provides various alternatives to a range of petroleum-sourced products worldwide. The company uses its industrial bioscience technology to design microbes primarily yeast, as well as to convert plant-sourced sugars into renewable hydrocarbons. It produces and sells Biofene that converts to squalane, which is used as an emollient in cosmetics and other personal care products; and natural oils and aroma chemicals for the flavors and fragrances market. The company also provides renewable solvents, polymers, and renewable lubricants for industrial applications; and renewable fuels for transportation fuels market. It has a collaboration partnership with Total S.A. to produce and commercialize Biofene-based diesel and jet fuels. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was founded in 2003 and is headquartered in Emeryville, California.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Amyris, Inc.

    Corporate Governance 
    Amyris, Inc.’s ISS Governance QuickScore as of Jul 1, 2015 is 10. The pillar scores are Audit: 2; Board: 8; Shareholder Rights: 8; Compensation: 10.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
     PayExercised
    Mr. John G. Melo , 50
    Chief Exec. Officer, Pres and Director
    822.00K0.00
    Mr. Raffi Mark Asadorian , 47
    Chief Financial Officer
    567.00K0.00
    Mr. Nicholas S. Khadder , 42
    Sr. VP, Gen. Counsel and Corp. Sec.
    361.00K0.00
    Dr. Joel R. Cherry Ph.D., 55
    Pres of R&D
    439.00K0.00
    Ms. Karen Weaver , 55
    Principal Accounting Officer, VP of Fin. and Corp. Controller
    N/AN/A
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders